3B BLACKBIO DX LTD. Financial Ratios
3BBLACKBIO · Healthcare · Current price ₹1,250.4
P/E ratio
18.3x
P/B ratio
3.2x
ROE
19.8%
ROCE
25.0%
Debt / Equity
—
Dividend yield
—
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 18.3x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 3.2x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 19.8% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 25.0% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | — | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with 3B BLACKBIO DX LTD.'s latest numbers.
3B BLACKBIO DX LTD. profitability
3B BLACKBIO DX LTD. generates a return on equity of 19.8% and a return on capital employed of 25.0%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of n/a and a P/E of 18.3x, 3B BLACKBIO DX LTD. is conservatively financed. Our overall business-quality score for the company is 6.1 / 10.
Understand the ratios
More on 3B BLACKBIO DX LTD.
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.